Skip to main content
OpenTrials
Completed

NCT Number: NCT02243020

VNS During Rehabilitation for Improved Upper Limb Motor Function After Stroke

The primary study objectives are to assess the safety and feasibility of the therapy, including the surgical intervention and stimulation, as well as to provide information on the appropriateness of the study test measures (assessments) and to provide a basis for sample size calculations for a larger, pivotal study.

Completed

Looking for future studies?

Notify Me

Key information

Age range

30 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Minnesota, Minneapolis, Minnesota, United States

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • History of ischemic stroke that occurred at least 4 months prior to enrollment, but not more than 24 months prior
  • Age >30 years and <80 years
  • Right or left sided weakness of upper extremity
  • UEFM score within designated range.
  • At least 10 degrees of wrist extension, 10° of thumb abduction/extension, and at least 10° of extension in at least 2 additional digits

Exclusion criteria

  • History of hemorrhagic stroke
  • Any deficits in language or cognitive functioning that hinders participation, for example, (aphasia) or unable to follow 2 step commands.
  • Significant sensory loss.
  • Presence of ongoing dysphagia or aspiration difficulties.
  • Active major neurological or psychiatric diagnosis that would likely interfere with study protocol including prior history of brain lesions (including dementia, etc.), and current alcohol abuse, drug abuse, or epilepsy.
  • Subject receiving any therapy (medication or otherwise) at study entry that would interfere with VNS (e.g. drugs that interfere with neurotransmitter mechanisms). Additionally, no psychoactive medications - including nicotine - may be used during the acute study.
  • Prior injury to vagus nerve - either bilateral or unilateral (e.g., injury during carotid endarterectomy)
  • Severe depression
  • Not considered candidate for a device implant surgery (history of adverse reactions to anesthetics, poor surgical candidate in surgeon's opinion, etc.)
  • Any other implanted device such as a pacemaker or other neurostimulator; any other investigational device or drug
  • Medical or mental instability (diagnosis of personality disorder, psychosis, or substance abuse)
  • Pregnant or plan on becoming pregnant or breastfeeding during the study period
  • Currently require, or likely to require, diathermy during the study duration
  • Any health problem requiring surveillance with MRI imaging
  • Active rehabilitation within 4-weeks prior to therapy
  • Botox injections or any other non-study active rehabilitation of the upper extremity 4-weeks prior to and during therapy
  • Severe spasticity of the upper limb

Treatment and study plan

Vagus Nerve Stimulation (VNS)

Device

Other names: VNS

Primary outcomes

  1. Change in Upper Extremity Fugl-Meyer (UEFM)

    Time frame: 6-weeks

    Measurement of impairment, minimum value 0, maximum value 66, higher score means a better outcome. Subscales are summed.

Secondary outcomes

  1. Change in Wolf Motor Function Test Functional Assessment (WMFT)

    Time frame: 6-weeks

    Measurement of upper limb function/mobility. For Functional Assessment - minimum is 0 and maximum is 3. A higher score means a better outcome.

Sponsors and collaborators

Lead sponsor

MicroTransponder Inc.

Industry

Registry information

Official study title

Study MT-St-02 - Stroke - A Randomized Pilot Study Assessing Vagus Nerve Stimulation (VNS) During Rehabilitation for Improved Upper Limb Motor Function After Stroke (MicroTransponder's Vivistim System)

Important dates

Study start
2014
Primary completion
2016
Study completion
2022
First posted
Sep 17, 2014
Registry last updated
Sep 15, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.